United States · FDA National Drug Code directory
Fetroja
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59630-266_64c35e73-1daa-4a82-a3c2-a737dec6eeae
- Product NDC
- 59630-266
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Cefiderocol sulfate tosylate
- Labeler
- Shionogi Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200131
- Source listing expiry
- 20271231
Source-listed ingredients
- CEFIDEROCOL SULFATE TOSYLATE — 1 g/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-USE in 1 CARTON (59630-266-10) / 10 mL in 1 VIAL, SINGLE-USE (59630-266-01) · 59630-266-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →